🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nagsen Gautam

Arrowhead Pharmaceuticals (United States)

ORCID: 0000-0001-5876-6760
Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.

46 citations

Brady Sillman, Aditya N. Bade, Sean N. Avedissian, Anthony T. Podany, JoEllyn McMillan +18 more

53 citations

Nathan Smith, Suyash Deodhar, Aditya N. Bade, Nagsen Gautam, Bhagya Laxmi Dyavar Shetty +6 more

45 citations

JoEllyn McMillan, Devendra Kumar, Aditya N. Bade, Qiaoyu Pan, Tanmay A. Kulkarni +9 more

20 citations

Sushil Kumar, Nagsen Gautam, Anthony T. Podany, Lee C. Winchester, Jonathan A. Weinhold +5 more

1 citations

Lauren Lesiak, Christopher D. Aretz, Yu Du, Sushil Kumar, Nagsen Gautam +6 more

42 citations

Nagsen Gautam, Yazen Alnouti, Devendra Kumar

13 citations

Satish Sagar, Sydney P. Kubica, Lidia Boghean, Smit Kour, Hannah M. King +19 more

8 citations

Surendra K. Shukla, Asserewou Etekpo, Venugopal Gunda, Sharalyn Steenson, Nagsen Gautam +3 more

0 citations

Brady Sillman, Aditya N. Bade, JoEllyn McMillan, Nagsen Gautam, Brandon Hanson +15 more

9 citations

Gang Zhao, Xiaobei Wang, Nagsen Gautam, Zhenshan Jia, Zhifeng Zhao +14 more